ASCENTAGE PHARM. DL-0001(36X) News

Date	Title
Apr 21	Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
Dec 27	Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference